文献速递主动脉疾病

急性肾损伤严重程度与开窗和分支腔内主动脉瘤修复术后生存率下降相关

Severity of acute kidney injury is associated with decreased survival after fenestrated and branched endovascular aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2023-06-16

基于美国主动脉研究联盟10项前瞻性、非随机、医生发起的IDE研究(2005-2023年)中2413例接受开窗和分支腔内主动脉瘤修复术(F/B-EVAR)的患者,急性肾损伤(AKI)发生率为18%,且AKI严重程度与术后生存率下降相关。多变量分析显示AKI分期越高,死亡风险越高,基线eGFR、红细胞压积、肾动脉技术失败和手术时间与AKI严重程度相关。

要点

  • F/B-EVAR术后AKI发生率为18%,其中1期13%、2期2%、3期3%。
  • AKI严重程度与30天主要不良事件和术后生存率下降独立相关。
  • 基线eGFR、红细胞压积、肾动脉技术失败和手术时间是AKI严重程度的预测因素。

核心结论

  • 按2012年KDIGO标准定义的AKI在F/B-EVAR术后发生于18%的患者,且AKI严重程度越高术后生存率越低。

研究设计与样本

  • 美国主动脉研究联盟10项前瞻性、非随机、医生发起的IDE研究(2005-2023年)连续入组2413例F/B-EVAR患者,中位年龄74岁,中位随访2.2年。

主要发现

  • AKI分期:1期316例(13%)、2期42例(2%)、3期74例(3%);36例(1.5%)住院期间启动肾脏替代治疗,占3期AKI的49%。
  • 1年未调整生存率:无AKI 91%(95%CI 90%-92%)vs 1期80%(95%CI 76%-85%)vs 2期72%(95%CI 59%-87%)vs 3期46%(95%CI 35%-59%),P<.0001。
  • AKI严重程度预测因素:基线eGFR每10 mL/min/1.73m2比例优势比0.9(95%CI 0.85-0.95);基线红细胞压积每10%为0.58(95%CI 0.48-0.71);肾动脉技术失败OR 3(95%CI 1.61-5.72);总手术时间每10分钟OR 1.05(95%CI 1.04-1.07)。
  • 生存多变量决定因素:AKI 1期HR 1.6(95%CI 1.3-2)、2期HR 2.2(95%CI 1.4-3.4)、3期HR 4(95%CI 2.9-5.5);eGFR降低HR 1.1(95%CI 0.9-1.3,P=.4);年龄每10岁HR 1.6(95%CI 1.4-1.8);COPD HR 1.5(95%CI 1.3-1.8);CHF HR 1.7(95%CI 1.6-2.1);术后截瘫HR 2.1(95%CI 1.1-4);技术成功HR 0.6(95%CI 0.4-0.8)。
  • 30天主要不良事件与AKI严重程度相关(所有P≤.0001)。

关键数值与推荐

  • AKI定义与分期采用2012年KDIGO标准。
  • AKI严重程度多变量预测模型采用向后逐步混合效应多变量有序logistic回归。
  • 生存分析采用条件调整生存曲线和向后逐步混合效应Cox比例风险模型。

临床怎么用

  • 作者认为,这些分析中识别的AKI严重程度预测因素提示改善术前风险缓解和复杂主动脉修复干预分期可能发挥作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Acute kidney injury (AKI) occurs frequently in complex aortic surgery and has been implicated in perioperative and long-term survival. This study sought to characterize the relationship between AKI severity and mortality after fenestrated and branched endovascular aortic aneurysm repair (F/B-EVAR). METHODS: Consecutive patients enrolled by the US Aortic Research Consortium in 10, prospective, nonrandomized, physician-sponsored investigational device exemption studies evaluating F/B-EVAR, between 2005 and 2023, were included in this study. Perioperative AKI during hospitalization was defined by and staged using the 2012 Kidney Disease Improving Global Outcomes criteria. Determinants of AKI were evaluated with backward stepwise mixed effects multivariable ordinal logistic regression. Survival was analyzed with conditionally adjusted survival curves and backward stepwise mixed effects Cox proportional hazards modelling. RESULTS: In the study period, 2413 patients with a median (interquartile range [IQR]) age of 74 years (IQR, 69-79 years) underwent F/B-EVAR. The median follow-up duration was 2.2 years (IQR, 0.7-3.7 years). The median baseline estimated glomerular filtration rate (eGFR) and creatinine were 68 mL/min/1.73 m2 (IQR, 53-84 mL/min/1.73 m2) and 1.1 mg/dL (IQR, 0.9-1.3 mg/dL), respectively. Stratification of AKI identified 316 patients (13%) with stage 1 injury, 42 (2%) with stage 2 injury, and 74 (3%) with stage 3 injury. Renal replacement therapy was initiated during the index hospitalization in 36 patients (1.5% of cohort, 49% of stage 3 injuries). Thirty-day major adverse events were associated with AKI severity (all P ≤ .0001). Multivariable predictors of AKI severity included baseline eGFR (proportional odds ratio, 0.9 per 10 mL/min/1.73 m2 [95% confidence interval (CI), 0.85-0.95 per 10 mL/min/1.73 m2]; P < .0001), baseline serum hematocrit (0.58 per 10% [95% CI, 0.48-0.71 per 10%]; P < .0001), renal artery technical failure during aneurysm repair (3 [95% CI,1.61-5.72]; P = .0006), and total operating time (1.05 per 10 minutes [95% CI, 1.04-1.07 per 10 minutes]; P < .0001). One-year unadjusted survivals for AKI severity strata were 91% (95% CI, 90%-92%) for no injury, 80% (95% CI, 76%-85%) for stage 1 injury, 72% (95% CI, 59-87%) for stage 2 injury, and 46% (95% CI, 35-59%) for stage 3 injury (P<.0001). Multivariable determinants of survival included AKI severity (stage 1, hazard ratio [HR], 1.6 [95% CI, 1.3-2]); stage 2, HR, 2.2 [95% CI, 1.4-3.4]); stage 3 HR, 4 [95% CI, 2.9-5.5]; P < .0001), decreased eGFR (HR, 1.1 [95% CI, 0.9-1.3]; P = .4), patient age (HR, 1.6 per 10 years [95% CI, 1.4-1.8 per 10 years]; P < .0001), baseline chronic obstructive pulmonary disease (HR, 1.5 [95% CI, 1.3-1.8]; P < .0001), baseline congestive heart failure (HR, 1.7 [95% CI, 1.6-2.1]; P < .0001), postoperative paraplegia (HR, 2.1 [95% CI, 1.1-4]; P = .02), and procedural technical success (HR, 0.6 [95% CI, 0.4-0.8]; P = .003). CONCLUSIONS: AKI, as defined by the 2012 Kidney Disease Improving Global Outcomes criteria, occurred in 18% of patients after F/B-EVAR. Greater severity of AKI after F/B-EVAR was associated with decreased postoperative survival. The predictors of AKI severity identified in these analyses suggest a role for improved preoperative risk mitigation and staging of interventions in complex aortic repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Finnesgard EJ, Beck AW, Eagleton MJ, et al. Severity of acute kidney injury is associated with decreased survival after fenestrated and branched endovascular aortic aneurysm repair. J Vasc Surg. 2023. PMID: 37330702. doi:10.1016/j.jvs.2023.05.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。